Advalytix AG

Munchen, Germany Founded: 2000 • Age: 26 yrs Acquired By Beckman Coulter
Provides single cell molecular analysis, and the miniaturization of biological tests for RD

About Advalytix AG

Advalytix AG is a Healthcare company based in Munchen (Germany) founded in 2000, and was acquired by Beckman Coulter in June 2009. It provides single cell molecular analysis, and the miniaturization of biological tests for RD.

Company details

Advalytix provides cell-based molecular diagnostics with main focus is the miniaturization of diagnostic and biological tests for RD. It was initially a Cipio Partner portfolio company and later from 2005 was a wholly owned subsidiary of Olympus Life and Material Science Europa. Its products link imaging technologies such as microscopy with nucleic acid analysis, enabling to offer turnkey system solutions consisting of both instruments and reagents. It was acquired by Beckman coulter in 2009 and is currently a team within Beckman Coulter Genomics.

  • Headquarters Munchen, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website advalytix.com
  • Social LinkedIn
  • Acquired by Beckman Coulter (Jun 2009)
Key Metrics

Investors in Advalytix AG

Advalytix AG has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.

All
InvestorDescriptionFounded YearDomainLocation
Clinical diagnostic products are manufactured for biomedical testing.
1935beckmancoulter.comBrea, United States
Premium access

Investor details for Advalytix AG

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Advalytix AG

2 dated milestones of Advalytix AG across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Advalytix AG is founded.
  2. Exit Acquired by Beckman Coulter.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Advalytix AG

Advalytix AG was founded in 2000.

Advalytix AG is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.

Advalytix provides cell-based molecular diagnostics with main focus is the miniaturization of diagnostic and biological tests for RD. It was initially a Cipio Partner portfolio company and later from 2005 was a wholly owned subsidiary of Olympus Life and Material Science Europa. Its products link imaging technologies such as microscopy with nucleic acid analysis, enabling to offer turnkey system solutions consisting of both instruments and reagents. It was acquired by Beckman coulter in 2009 and is currently a team within Beckman Coulter Genomics.

Advalytix AG has 1 investor. Key investors include Beckman Coulter.

Yes. Advalytix AG was acquired by Beckman Coulter in June 2009.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available